Gary L. Crocker's most recent trade in Merrimack Pharmaceuticals Inc was a trade of 2,000 Common Stock done at an average price of $12.5 . Disclosure was reported to the exchange on Aug. 10, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 12.52 per share. | 10 Aug 2023 | 2,000 | 133,105 (0%) | 0% | 12.5 | 25,039 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 12.43 per share. | 10 Aug 2023 | 2,000 | 133,105 (0%) | 0% | 12.4 | 24,865 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 8,000 | 32,000 | - | - | Stock Option (right to buy) | |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.15 per share. | 09 Jun 2022 | 4,452 | 131,105 (0%) | 0% | 5.1 | 22,918 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.14 per share. | 07 Jun 2022 | 349 | 126,653 (0%) | 0% | 5.1 | 1,795 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.05 per share. | 07 Jun 2022 | 300 | 126,304 (0%) | 0% | 5.1 | 1,515 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 8,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.09 per share. | 24 May 2022 | 2,323 | 125,872 (0%) | 0% | 5.1 | 11,817 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.14 per share. | 24 May 2022 | 132 | 126,004 (0%) | 0% | 5.1 | 678 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.04 per share. | 19 May 2022 | 512 | 123,549 (0%) | 0% | 5.0 | 2,582 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.08 per share. | 17 May 2022 | 5,000 | 123,037 (0%) | 0% | 5.1 | 25,407 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.10 per share. | 17 May 2022 | 225 | 118,037 (0%) | 0% | 5.1 | 1,147 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.04 per share. | 12 May 2022 | 2,471 | 117,809 (0%) | 0% | 5.0 | 12,456 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 May 2022 | 3 | 117,812 (0%) | 0% | 5 | 15 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 21 Apr 2022 | 5,000 | 115,338 (0%) | 0% | 6.0 | 30,001 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.18 per share. | 30 Mar 2022 | 300 | 110,338 (0%) | 0% | 6.2 | 1,853 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.20 per share. | 30 Mar 2022 | 161 | 110,038 (0%) | 0% | 6.2 | 998 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.16 per share. | 28 Mar 2022 | 5,000 | 109,877 (0%) | 0% | 6.2 | 30,822 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.12 per share. | 22 Mar 2022 | 400 | 104,877 (0%) | 0% | 6.1 | 2,446 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.14 per share. | 15 Mar 2022 | 4,649 | 104,477 (0%) | 0% | 6.1 | 28,556 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.08 per share. | 11 Mar 2022 | 5,000 | 94,828 (0%) | 0% | 6.1 | 30,407 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.02 per share. | 11 Mar 2022 | 5,000 | 99,828 (0%) | 0% | 6.0 | 30,121 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.96 per share. | 18 Feb 2022 | 3,351 | 89,828 (0%) | 0% | 6.0 | 19,970 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.20 per share. | 16 Feb 2022 | 7,945 | 81,477 (0%) | 0% | 6.2 | 49,231 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.13 per share. | 16 Feb 2022 | 5,000 | 86,477 (0%) | 0% | 6.1 | 30,626 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 5.96 per share. | 14 Feb 2022 | 1,800 | 73,409 (0%) | 0% | 6.0 | 10,724 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.20 per share. | 14 Feb 2022 | 123 | 73,532 (0%) | 0% | 6.2 | 763 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.60 per share. | 27 Jan 2022 | 673 | 71,609 (0%) | 0% | 4.6 | 3,096 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.56 per share. | 26 Jan 2022 | 3,100 | 70,936 (0%) | 0% | 4.6 | 14,121 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.33 per share. | 21 Jan 2022 | 7,105 | 67,836 (0%) | 0% | 4.3 | 30,741 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.66 per share. | 21 Jan 2022 | 2,000 | 60,731 (0%) | 0% | 4.7 | 9,310 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.54 per share. | 18 Jan 2022 | 5,000 | 58,731 (0%) | 0% | 4.5 | 22,690 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.51 per share. | 13 Jan 2022 | 5,000 | 53,731 (0%) | 0% | 4.5 | 22,554 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.42 per share. | 13 Jan 2022 | 5,000 | 48,731 (0%) | 0% | 4.4 | 22,121 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.33 per share. | 11 Jan 2022 | 5,000 | 43,731 (0%) | 0% | 4.3 | 21,658 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 4.03 per share. | 11 Jan 2022 | 5,000 | 38,731 (0%) | 0% | 4.0 | 20,141 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.07 per share. | 12 Apr 2021 | 973 | 33,731 (0%) | 0% | 6.1 | 5,905 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.10 per share. | 09 Apr 2021 | 1,200 | 32,758 (0%) | 0% | 6.1 | 7,320 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.19 per share. | 07 Apr 2021 | 2,127 | 31,558 (0%) | 0% | 6.2 | 13,166 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.19 per share. | 31 Mar 2021 | 500 | 29,431 (0%) | 0% | 6.2 | 3,095 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.13 per share. | 25 Mar 2021 | 200 | 28,931 (0%) | 0% | 6.1 | 1,226 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.34 per share. | 23 Mar 2021 | 5,000 | 28,731 (0%) | 0% | 6.3 | 31,690 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.47 per share. | 23 Mar 2021 | 3,627 | 23,731 (0%) | 0% | 6.5 | 23,455 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 6.79 per share. | 16 Mar 2021 | 5,000 | 20,104 (0%) | 0% | 6.8 | 33,956 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 7.20 per share. | 23 Feb 2021 | 5,000 | 15,104 (0%) | 0% | 7.2 | 36,005 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 7.47 per share. | 12 Feb 2021 | 5,000 | 10,104 (0%) | 0% | 7.5 | 37,342 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 7.64 per share. | 10 Feb 2021 | 3,500 | 3,500 (0%) | 0% | 7.6 | 26,757 | Common Stock |
| Merrimack Pharmaceuticals Inc | Gary L. Crocker | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 7.98 per share. | 10 Feb 2021 | 1,604 | 5,104 (0%) | 0% | 8.0 | 12,798 | Common Stock |